Home
Conditions
Lentivirus Infections

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,640 public trials 304 recruiting studies

Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects

NCT00144261

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: 1100.1426.01 Academic Medical Centre Amsterdam, Netherlands

1100.1426.02 Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands

1100.1426.44001 Boehringer Ingelheim Investigational Site London, United Kingdom

View Trial Details

Completed

Aging With HIV and Neurocognitive Decline, a Follow-up Study

NCT05385588

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Hôpital Pellegrin Bordeaux, France

Hôpital Saint André Bordeaux, France

CH Cannes Cannes, France

CHD Vendée La Roche-sur-Yon, France

View Trial Details

Completed

Zepatier in Patients with Substance Use

NCT04048850

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chemically-Induced Disorders, +25 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

View Trial Details

Completed

COVID-19 Serology in People Living with HIV in Hong Kong

NCT05028881

Conditions: Blood-Borne Infections, COVID-19, Coinfection, +23 more
Locations: Shui Shan Lee Hong Kong, China

View Trial Details

Completed

A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP

NCT04066881

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: MRC/UVRI and LSHTM Uganda Research Unit Entebbe, Uganda

View Trial Details

Completed

'COMBINE-2': Real-world Evidence for Effectiveness of Two Drug Regimen, Antiretroviral Therapy With Integrase Inhibitors Plus a Reverse Transcriptase Inhibitor

NCT04019873

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: GSK Investigational Site Barcelona, Spain

View Trial Details

Completed

A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women

NCT04758390

Conditions: Blood-Borne Infections, Communicable Diseases, Disease Attributes, +15 more
Locations: Desmond Tutu Health Foundation Cape Town, South Africa

View Trial Details

Completed

A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)

NCT06783192

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations: QPS-MRA, LLC-Early Phase (Site 0001) South Miami, Florida, United States

View Trial Details

Completed

Improving Treatment and Retention Adherence in Nontraditional Settings

NCT04973254

Conditions: Behavior, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Boston Medical Center, Center for Infectious Disease Boston, Massachusetts, United States

Boston Medical Center, Project Trust Boston, Massachusetts, United States

View Trial Details

Completed

Tailored Motivational Interviewing Implementation-Effectiveness Trial in Multidisciplinary Adolescent HIV Care Settings

NCT03681912

Conditions: Adolescent Development, Behavior, Blood-Borne Infections, +21 more
Locations: Wayne State University Detroit, Michigan, United States

View Trial Details

Lentivirus Infections

Lentivirus Infections trial results

Related conditions